Homocysteine is an amino acid in the blood that's a byproduct of protein metabolism. Elevated levels of homocysteine, known as hyperhomocysteinemia, have been associated with an increased risk of cardiovascular diseases, such as heart attacks and strokes. High homocysteine levels can damage the lining of arteries and promote blood clot formation, leading to atherosclerosis, a condition characterized by narrowed and hardened arteries. Additionally, elevated homocysteine has been linked to an increased risk of venous thrombosis, where clots form in the veins.
Apart from cardiovascular risks, high levels of homocysteine have been implicated in other health issues. These include osteoporosis, where high homocysteine levels may interfere with collagen cross-linking, weakening bones and increasing the risk of fractures. There's also evidence suggesting that hyperhomocysteinemia may be associated with Alzheimer's disease, dementia, and decreased cognitive function, although the exact mechanisms are not fully understood. Elevated homocysteine levels can result from a deficiency of vitamins B6, B9 (folate), and B12, kidney disease, genetic factors, certain medications, and lifestyle factors such as smoking and excessive alcohol consumption.
On the other hand, very low homocysteine levels are rare and generally not considered a health risk. The focus in clinical practice is typically on managing high homocysteine levels, often through dietary changes and supplementation with B vitamins, particularly B6, B9, and B12, which help break down homocysteine in the body. Maintaining balanced homocysteine levels is important for cardiovascular and bone health, as well as for cognitive function.
To maintain healthy homocysteine levels:
Ensure an adequate intake of B vitamins, particularly B6, B9 (folate), and B12, through a balanced diet or supplementation if necessary. Good sources include leafy greens, fortified grains, legumes, and lean meats.
Adopt a heart-healthy lifestyle, including regular exercise, maintaining a healthy weight, and avoiding smoking and excessive alcohol consumption.
If you have a family history of hyperhomocysteinemia or are at increased risk for cardiovascular disease, work with your healthcare provider to monitor your homocysteine levels and develop a personalized management plan.
If you have a chronic condition such as kidney disease that may affect homocysteine levels, work closely with your healthcare team to manage the condition and monitor your homocysteine levels.
Homocysteine can be measured in: mg/100mL, mg/dL, mg/L, mg%, µg/mL, µmol/L
Reference ranges represent typical values for healthy individuals. Your healthcare provider must interpret your specific results.
| Age Range | Gender | Unit | Optimal | Normal | Source |
|---|---|---|---|---|---|
| 15 - 65 | All genders | µmol/L | - | 0 - 15 | Burnham, 2023 |
| 65 - ∞ | All genders | µmol/L | - | 0 - 20 | Burnham, 2023 |
Elevated levels of homocysteine have been linked to increased risk of fractures and poor bone health. Homocysteine may interfere with collagen cross-linking, impacting bone strength. It’s often measured in individuals with a history of fractures or osteoporosis.[van Meurs, 2004][McLean, 2004][McLean, 2008][Koh, 2006]
Explore 1 additional health topic related to this biomarker in the Health3 app.
Elevated homocysteine levels can negatively affect lipid metabolism, leading to unfavorable changes in lipid profiles. These changes can exacerbate the risk of cardiovascular disease[Daly, 2009][Momin, 2017].
Vitamin B6 is involved in the conversion of homocysteine to cysteine. Adequate levels of vitamin B6 are necessary to maintain normal homocysteine levels. A deficiency in vitamin B6 can result in elevated homocysteine, which is a risk factor for cardiovascular disease.[Selhub, 1999]
Elevated homocysteine levels can negatively affect lipid metabolism, leading to unfavorable changes in lipid profiles. These changes can exacerbate the risk of cardiovascular disease[Daly, 2009][Momin, 2017].
Explore 5 additional biomarker interactions related to this biomarker in the Health3 app.
Homocysteine is a sulphur-containing amino acid produced during the metabolism of methionine (an essential amino acid found in protein-rich foods). Unlike dietary amino acids, homocysteine is not obtained from food — it is an intermediate metabolite. In a healthy body, homocysteine is rapidly converted back to methionine (requiring folate and vitamin B12) or converted to cystathionine (requiring vitamin B6). When these B-vitamin cofactors are insufficient — or certain enzymes are defective — homocysteine accumulates in the blood.
Elevated homocysteine (hyperhomocysteinaemia) is a well-established risk marker for cardiovascular disease, stroke, and venous thromboembolism. It has also been linked to cognitive decline and bone fragility. Because homocysteine is directly modifiable through B-vitamin supplementation, it is both an informative marker and a potential intervention target. See the Cardiovascular Health topic page and the B vitamins blood test guide.
Reference ranges vary between laboratories. Some experts use an optimal target of <7 µmol/L for cardiovascular prevention, particularly in people with other risk factors. Homocysteine increases with age, renal impairment, and is typically higher in men than women. Use the blood test unit converter if your lab reports in mg/L (multiply µmol/L by 0.135).
The most common cause of elevated homocysteine is nutritional deficiency — particularly low folate (B9), vitamin B12, and vitamin B6, all of which are required for homocysteine metabolism. Other causes include:
What elevated homocysteine does to the body: High homocysteine damages vascular endothelium, promotes oxidative stress, activates platelet aggregation, and impairs colagen cross-linking. These mechanisms contribute to atherosclerosis, arterial stiffness, and thrombosis risk.
The following associations are well-established in observational literature; note that reducing homocysteine via B-vitamin supplementation has shown mixed results in RCTs for some endpoints:
Elevated homocysteine driven by B-vitamin deficiency is highly responsive to supplementation. The standard approach:
Dietary changes — increasing folate-rich foods (leafy greens, legumes, fortified cereals) and B12 sources (meat, fish, dairy, or fortified plant milks for vegans) — are the first-line approach. Monitoring homocysteine after 8–12 weeks of intervention confirms response.
Since homocysteine is a risk marker that responds to intervention, tracking it over time is particularly informative. A single elevated reading should prompt checking folate, B12, and B6 status, renal function (creatinine, eGFR), and thyroid function (TSH). Retesting after 2–3 months of supplementation confirms whether levels have normalised.
People with the MTHFR C677T variant may find their homocysteine remains borderline elevated despite standard supplementation, in which case a methylated B-vitamin formula and attention to dietary folate may be more effective.
Most laboratories define normal as below 10–15 µmol/L. Many cardiovascular prevention specialists prefer a target below 10 µmol/L, and some use an optimal target of <7 µmol/L. Levels typically increase with age and are higher in men than women by about 2–3 µmol/L on average.
High homocysteine most commonly indicates deficiency in folate, B12, or B6. It can also reflect kidney disease, hypothyroidism, MTHFR gene variants, or medication effects. It is an independent cardiovascular and neurocognitive risk marker. Importantly, it is one of the few cardiovascular risk factors that is both measurable with a simple blood test and easily modifiable through dietary changes and supplementation.
Folate-rich foods (leafy green vegetables, lentils, beans, asparagus, fortified cereals), B12-rich foods (meat, fish, dairy, eggs, or fortified plant milks), and B6-rich foods (poultry, fish, potatoes, bananas). A Mediterranean-style diet is associated with lower homocysteine levels.
The MTHFR C677T variant reduces enzyme activity by 30–60%, which can impair folate conversion to its active form (5-MTHF) and lead to mildly elevated homocysteine. It is common (30–40% of the general population carry at least one copy). Most people with this variant can normalise homocysteine with adequate folate and B12 intake; methylated forms of these vitamins may be particularly beneficial.
B-vitamin supplementation reliably lowers homocysteine (by 20–30%), but large RCTs have not consistently shown reduced rates of heart attacks or strokes in people who were not severely deficient. One important exception: studies suggest that B-vitamin supplementation reducing homocysteine in people with cognitive impairment does slow brain atrophy — suggesting the cognitive pathway may be more responsive. The field is still evolving.
Plasma homocysteine typically drops within 2–4 weeks of starting folate and B12 supplementation, with maximum response (20–30% reduction) usually achieved by 8–12 weeks. Retesting at 2–3 months after starting supplements is recommended to confirm response.
This page is for educational purposes only and does not constitute medical advice. Reference ranges vary between laboratories. Elevated homocysteine requires clinical evaluation to identify the cause before starting treatment. Always discuss results with a healthcare provider. Health3 is an educational tracking tool, not a diagnostic service.
Save this biomarker reference for your medical appointments
Was this information helpful?
Monitor your biomarkers, visualize trends, and share insights with your care team.